Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis

This study is ongoing, but not recruiting participants.

Study NCT00411723 Information provided by Artielle ImmunoTherapeutics

First Received: December 12, 2006 Last Updated: February 19, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	May 2009
Primary Completion Date:	February 2009 (Final data collection date for primary outcome measure)